OncLive® On Air

OncLive® On Air

Por: OncLive® On Air
In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers, hematologic malignancies, gynecologic cancers, genitourinary cancers, and more.

500 episodios disponibles

Latest episodes of the podcast OncLive® On Air

Mostrando página 11 de 25

S11 Ep28: Liquid Biopsy Ushers in a New Era of NSCLC Biomarker Testing: With David R. Gandara, MD 28/10/2024
S11 Ep27: Delve into Recent NCCN Guideline Updates for Hepatobiliary and CRC Management: With Alan P. Venook, MD 24/10/2024
S11 Ep26: Phase 1 Trials Provide Oncology Fellows With Valuable Clinical Research Experience: With Samuel A. Kareff, MD, MPH 21/10/2024
S11 Ep25: FDA Approval Insights: Denileukin Diftitox in Relapsed/Refractory CTCL 17/10/2024
S11 Ep24: How to Apply Research Developments in ALK-Positive NSCLC: With Chandler Park, MD, and Tejas Patil, MD 16/10/2024
S11 Ep23: Navigating Myelofibrosis: Updates for Community Hematologist Oncologists 14/10/2024
S11 Ep22: FDA Approval Insights: Vorasidenib in IDH1/2+ Grade 2 Astrocytoma and Oligodendroglioma 10/10/2024
S11 Ep21: Updated VISION Trial Data Showcase the Efficacy of Tepotinib in MET + NSCLC: With Martin Dietrich, MD 07/10/2024
S11 Ep20: FDA Approval Insights: Perioperative Durvalumab for Resectable NSCLC 03/10/2024
S11 Ep19: Immunotherapy Advances Expand the SCLC Treatment Paradigm: With Chandler Park, MD, and Tejas Patil, MD 02/10/2024
S11 Ep18: Board Review Resources 2024 30/09/2024
S11 Ep17: How Luspatercept Could Shake Up MDS Management—With Rory Shallis, MD 26/09/2024
S11 Ep16: FDA Approval Insights: Afami-Cel for Pretreated, Unresectable or Metastatic Synovial Sarcoma 23/09/2024
S11 Ep15: Thomas and Lukas Highlight Updates in Brain Cancer from the 2024 ASCO Annual Meeting 19/09/2024
S11 Ep14: Park and Patil Explore Advances in EGFR + NSCLC From ASCO 2024 18/09/2024
S11 Ep13: FDA Approval Insights: Epcoritamab in Relapsed/Refractory Follicular Lymphoma 16/09/2024
S11 Ep12: Oncology Experts Preview Top Abstracts From the 2024 ESMO Congress 11/09/2024
S11 Ep11: Heme & Onc Fellow Board Review Tips 2024 09/09/2024
S11 Ep10: Florez Focuses on Patient-Centered NSCLC Biomarker Testing Discussions 05/09/2024
S11 Ep9: Park and Graff Explore the Evolving Role of CDK4/6 Inhibitors in Metastatic Breast Cancer 04/09/2024
« Primera ‹ Anterior 1 ... 9 10 11 12 13 ... 25 Siguiente › Última »
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA